<DOC>
	<DOCNO>NCT00160576</DOCNO>
	<brief_summary>This 41-week trial compose two consecutive part ( Part A , 14 week optional Part B , 27 week ) evaluate efficacy levetiracetam control levodopa induce dyskinesias adult Idiopathic Parkinson 's Disease , without negative impact benefit motor function antiparkinsonian treatment .</brief_summary>
	<brief_title>Levetiracetam Treatment Adult Subjects With Parkinson 's Disease Experiencing Troublesome Dyskinesias</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<mesh_term>Dyskinesias</mesh_term>
	<mesh_term>Etiracetam</mesh_term>
	<mesh_term>Piracetam</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>1 . Male / female adult , 30 year old ; 2 . Subject suffer Idiopathic Parkinson 's Disease , diagnose accord UK Brain Bank Criteria ( see Appendix 14.8 ) ( 1 ) , since minimum 3 year , stabilize regard motor function ( ratio .on./.off . day ) ; 3 . Subject treat levodopa whether combined antiparkinsonian drug ( except apomorphine ) minimum one year ; 4 . Subject experience .on . period , despite several attempt treatment adjustment , persistent troublesome dyskinesia : 1. minimum score 2 item 33 UPDRSPart IV ( moderately disable dyskinesia ) ; 2. minimum score 2 item 32 UPDRSPart IV ( dyskinesias present 25 % waking day ) . 1 . Dyskinesias reliably characterize regular basis subject himself/herself ( 5 .errors . DRC per 24 hour repeat training ) ; 2 . Subject currently treat apomorphine neuroleptic drug either typical atypical clozapine , olanzapine risperidone ; 3 . Subject currently treat dopamine antagonist limit metoclopramide , alizapride phenothiazine derivative ( e.g . metopimazine ) . If necessary , use dopamine antagonist domperidone allow . 4 . Subject Who undergo schedule functional neurosurgery Parkinson 's disease trial period ;</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Idiopathic Parkinson 's Disease , levodopa induce dyskinesia ,</keyword>
	<keyword>Levetiracetam , Keppra</keyword>
</DOC>